Tarceva-7631hkg.7z -

It is approved for use in combination with gemcitabine chemotherapy for patients with advanced, previously untreated pancreatic cancer. Common Side Effects

It works by blocking chemical signals that cause cancer cells to grow and divide. Tarceva-7631HKG.7z

It is used for locally advanced or metastatic NSCLC that has specific EGFR exon 19 deletions or exon 21 (L858R) substitution mutations. It is used for both first-line treatment and as maintenance therapy after previous chemotherapy. It is approved for use in combination with

While effective, Tarceva can cause significant side effects that require monitoring: Erlotinib (Tarceva) - Cancer Research UK Tarceva-7631HKG.7z